TGF-beta Ligand Design via Subdomain Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods face challenges in specifically modifying and generating significant quantities of Transforming Growth Factor-beta (TGF-β) ligands, which are essential for therapeutic applications due to their role in developmental and cellular processes.
Innovation Solution
The development of recombinant chimeric polypeptides composed of segments from parental TGF-beta proteins, specifically designed to modulate pathways associated with the TGF-beta family, such as the SMAD or DAXX pathway, by selecting and conjoining sequence segments to create novel ligands with unique properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional methods are used to modify TGF-β ligands, then the ability to specifically alter properties is limited, but the complexity of new methods required to achieve specific modification is increased
Solution Approach 1:
The TGF-β ligand is divided into six distinct subdomains (numbered 1-6) that can be independently manipulated. This segmentation allows specific regions to be modified while preserving overall structure and function, enabling targeted property alteration without requiring complete redesign of the ligand.
Solution Approach 2:
Different subdomains of the TGF-β ligand are assigned specific functional roles (e.g., receptor binding, dimerization, stability). By modifying only the relevant local subdomain rather than the entire ligand, specific properties can be altered while maintaining other critical functions, thus improving adaptability without proportionally increasing complexity.
2Productivity
If natural TGF-β ligands are used for therapeutic applications, then biological activity is achieved, but the ability to generate significant quantities with desired properties is limited
Solution Approach 1:
The six-subdomain framework provides a universal platform that can generate multiple different TGF-β ligand variants with distinct therapeutic properties. By combining different sequences in each subdomain position, a library of ligands with varied activities can be created from a single modular design, increasing productivity while maintaining reliability through structure-activity relationship understanding.
3Adaptability or versatility
If the structural framework of TGF-β ligands is divided into six subdomains for modular design, then new ligands with unique properties can be created, but the complexity of designing and assembling these chimeric polypeptides increases
Solution Approach 1:
The TGF-β ligand is divided into six distinct subdomains (numbered 1-6) that can be independently manipulated. This segmentation allows specific regions to be modified while preserving overall structure and function, enabling targeted property alteration without requiring complete redesign of the ligand.
Solution Approach 2:
Chimeric TGF-β ligands are constructed by merging sequence segments from different parental TGF-β ligands at defined subdomain boundaries. This modular combining approach allows systematic generation of diverse ligand variants while maintaining structural integrity and simplifying the design process through standardized assembly rules.
Data Source
Figure 1A~1B
Figure 2
Figure 3
AI summary
The present disclosure relates to chimeric polypeptide having TGF- beta activity, nucleic acids encoding the polypeptides, and host cells for producing the polypeptides.